Article
PharmaVoice: What’s Next Post-COVID-19
The Next Normal
Nov 16, 2020
Download
From R&D to commercial operations, stakeholders across the healthcare ecosystem are adjusting to the next phase of the pandemic: business in a new reality. With some experts predicting that the “normalization” of business operations could be several months to a year away as the world awaits a vaccine or vaccines, organizations across the life-sciences industry are finding new paths forward as they adjust their operations to keep the engines running and the lights on. Virtual and digital are the new “in-person” connection. The pandemic has pushed companies to ramp up pilot programs and take a new look at risk- reward ratios. The world has changed and how much of this change will stick in the years or decades ahead depends on the willingness of company leaders to forge ahead into a future that is anything but business as usual.
Contact Us